Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing vascular calcification and skin necrosis, has been reported in patients taking warfarin.

Warfarin may promote vascular calcification in susceptible individuals. | iStock
Warfarin may promote vascular calcification in susceptible individuals. | iStock

An EU-wide review has concluded that there is a reasonable possibility that on rare occasions warfarin use might lead to calciphylaxis.

Further information
View warfarin drug records
MHRA Drug Safety Update
MIMS Cardiology Clinic

Calciphylaxis is most commonly observed in patients with end-stage renal disease on dialysis, or in those with known risk factors such as protein C or S deficiency, hyperphosphataemia, hypercalcaemia or hypoalbuminaemia.

Pre-existing renal disease was commonly reported in patients taking warfarin who developed calciphylaxis, but in some cases, affected patients had normal renal function.

If calciphylaxis is diagnosed, appropriate treatment should be started and consideration should be given to stopping treatment with warfarin.

Calciphylaxis, or calcific uraemic arteriolopathy, has a high mortality rate. Its exact pathogenesis is unknown but may involve the matrix Gla protein, a vitamin-K-dependent protein involved in the inhibition of calcification. Warfarin inhibits Gla protein and may therefore promote vascular calcification in susceptible individuals.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases